Glenmark Pharma recalls 1200 bottles of generic hypertension drug in US markets

29 Aug 2023 , 11:20 AM

According to the US Food and medicine Administration (FDA), Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic medicine used to treat high blood pressure in the American market owing to a manufacturing fault.

According to the current Enforcement Report of the US health authorities, the drug company’s New Jersey-based business is recalling 1,200 bottles of Trandolapril and Verapamil Hydrochloride extended-release tablets.

The company said that the affected lot had been manufactured at the Goa plant of Mumbai-based drug maker and then supplied to Glenmark Pharmaceuticals Inc, USA.

The contaminated bottles are being recalled because they are ‘Subpotent,’ according to the company. Glenmark Pharmaceuticals Inc began the countrywide (US) Class III recall on August 14, this year, according to the company. 

A Class III recall is launched when ‘use of, or exposure to, a violative product is not likely to cause adverse health consequences,’ according to the USFDA.

For feedback and suggestions, write to us at [e-mail]